Peripheral neuropathy occurs in association with paraproteinaemias of various causes (McLeod and Walsh, 1975; Read et al., 1978) but the pathogenesis of these neuropathies is obscure. In this paper we report experiments on the immunofluorescent binding of the paraprotein from two patients with paraproteinaemia and neuropathy to their own sural nerves, and to the sural nerves of five other patients, four with demyelinating or axonal neuropathies not associated with paraproteinaemias, and one without neuropathy or paraproteinaemia. Immunofluorescent binding of normal serum to these nerves was also studied.
Case reports CASE I
A 66 year old man presented with weakness and tingling in his legs. A chest radiograph in May 1976 revealed a small lobulated opacity in the right lower lobe but bronchoscopy and sputum cytology were both negative. The ankle jerks were absent, and there was a mild distal impairment of sensation, with a slightly ataxic gait. In May 1977 he was reassessed because of increasing difficulty with walking. There was slight weakness of the intrinsic muscles of both hands, with impaired two-point discrimination in the fingers; in the legs there was distal weakness and sensory impairment. The ankle jerks were absent but the other reflexes were just present. The left median motor nerve conduction velocity was 19 m/s, and an F wave study revealed a proximal conduction velocity of 25 m/s. The left sural sensory nerve action potential was absent. The chest radiograph showed no change in the small lesion in the right lower lobe. The ESR was 65 mm/hr. Serum protein electrophoresis showed a paraprotein. Immunoelectrophoresis revealed an IgA level of 1.7 g/l (normal 1.7-4.1 g/l), IgG 11.0 g/l (normal 6.0-12.0 g/l), and IgM 9.0 g/l (normal 0.6-1.8 g/l). Cases 3 and 4 showed the typical features of chronic Guillain-Barre syndrome including segmental demyelination with sparse inflammatory cell infiltrates, loss of myelin rings, and onion bulb formation. In case 5 there was axonal loss with regenerating axonal clusters. Remaining fibres were normally myelinated. In case 6 there was a severe demyelinating neuropathy with prominent onionbulb formation. There was no amyloid. In case 7 the sural nerve was normal.
IMMUNOFLUORESCENCE

Direct immunofluorescence
In cases 1 and 2 there was positive staining for IgM in the myelin sheaths of the degenerating nerve. The staining, most clearly identified in the cross section of the nerve, formed a collar in the thickness of the myelin sheath round the central, unstained axis cylinder (Fig. 2) . The IgM deposited in the myelin had the same kappa specificity as the serum paraprotein and as the urinary Bence-Jones protein (Table 1) . In case 2, although the serum IgM was polyclonal, with a mixture of kappa and lambda light chains, there was no staining of the myelin sheaths in the sural nerve biopsy specimen with either anti-kappa or anti-lambda conjugates. The IgM staining in this case was much weaker than in case 1, with less deposition of the immunoglobulin, and this probably accounts for the nega- 
Indirect immunofluorescence
To ascertain if the IgM-kappa paraprotein in case 1 had any affinity for normal or abnormal nerve, a number of the sural nerve samples were exposed in vitro to serum from case 1, and to a control serum with a normal level of polyclonal IgM (see Table 2 ). In case 4, one of the two patients with Guillain-Barre syndrome, there was positive staining of both myelin and perineurium after treatment with both case 1 serum (Fig. 3) , and normal serum (Fig. 4) . Staining was more intense with case 1 serum. In the other case of Guillain-Barre syndrome (case 3) there was no staining of the nerve by either case 1 or normal serum. In case 5, an axonal neuropathy, there was also positive staining after treatment with case 1 serum, but not after normal serum. Indirect staining in cases 4 and 5, was patchy, and appeared to be located superficially on the myelin sheath (Figs. 2 and 3) in contrast to the denser, full thickness staining seen by direct immunofluorescence in case 1 (Fig. 1) . (Propp et al., 1975; Hobbs et al., 1975) , and in the endoneurium and perineurium (Chazot et al., 1974 (Chazot et al., , 1976 in patients with Waldenstrom's macroglobulinaemia and peripheral neuropathy. In addition, monoclonal IgG and IgA has been found in nerve biopsy samples of patients with myeloma and peripheral neuropathy (Chazot et al.. 1976 ). However, peripheral neuropathy is an uncommon complication of paraproteinaemia. Chazot et al. (1976) found an incidence of only 9.8% in a series of 1602 patients with myeloma, Waldenstrom's macroglobulinaemia, and benign paraproteinaemia, and the significance of immunoglobulin binding to nerve in such cases is, therefore, uncertain. The presence of immunoglobulin bound to peripheral nerve might indicate a specific immunological reaction against antigen in the myelin shcath, endoneurium, or perineurium. This seems unlikely, however, since these structures differ antigenically. Moreover, practically all autoantibodies in sustained autoimmune responses are found in several immunoglobulin classes. For example, in case 1, a mitochondrial antibody was found in the IgA and IgG fractions, but not in the IgM fraction-that is, the autoantibody was polyclonal in respect of heavy chain class. On the other hand, monoclonal paraproteins have recently been shown to have identifiable antibody specificities of haptenic type (Seligmann and Brouet, 1973; Potter, 1977) . Another indication of possible specific antibody activity in tissue-deposited protein is the concomitant demonstration of complement, but no C3 was detected in either case 1 or case 2.
Van Lis and Jennekens (1977) showed that several plasma proteins, including immunoglobulins, could be identified in the epineurium, perineurium, and endoneurium of both abnormal and normal sural nerve biopsy samples. The distribution varied according to the pathology, and the molecular weight of the protein. They suggested that endoneurial blood vessels function as a barrier with graded permeability. In pathological conditions protein leakage might be increased, and reabsorption from nerves to vessels interrupted.
Significance of immunoglobulin deposition in peripheral nerve in neuropathie.J1 Olsson (1968) demonstrated abnormal permeability to albumin in peripheral nerves, particularly across endoneurial blood vessels, in rats treated with isoniazid for two weeks, suggesting that this neuropathy is associated with changes in the bloodnerve barrier. This mechanism might account for deposition of IgM in the abnormal nerves of our cases 1 and 2. Indeed, in our case 1 the neuropathy was predominantly demyelinating, and was associated not only with paraproteinaemia, but with carcinoma of the bronchus. The neuropathy associated with paraproteinaemia in myeloma and Waldenstrom's disease is typically axonal in type (McLeod and Walsh, 1975) although demyelinating neuropathy has rarely been reported with multiple myeloma (Mayo et al., 1965) . In case 2 the EMG and pathological findings were more typical of the axonal neuropathy usually associated with paraproteinaemia.
Our indirect immunofluorescent studies ( Propp et al. (1975) , showed no such affinity. None of these nerves showed direct immunofluorescent staining (Table 1) . Further, in case 4 indirect staining was present after exposure of the nerve specimen to normal serum. These experiments indicate an affinity of IgM (from case I serum) for myelin in both demyelinating and axonal neuropathies, suggesting that this affinity is not a specific autoimmune response. Indeed Carter (1977) found that 39 of 63 IgM paraproteins showed affinity for a wide range of axonal and glial antigens, but no such affinity was found in over 150 IgG or IgA paraproteins, or in patients with increased levels of polyclonal IgM.
We, therefore, suggest that there is no direct or causal relation between neuropathy and paraproteinaemia, but that the neuropathy is an associated feature of the underlying disorder, similar to the neuropathy associated with malignant disease. Immunoglobulin (IgM) deposition is probably a secondary process, accounted for by diffusion into damaged nerves, and by affinity between the IgM and peripheral nerve components, especially myelin sheath and perineurium. 
